Wat wij doen
Nieuws
VACSERA and Bilthoven Biologicals sign for polio vaccine manufacturing technology
Bilthoven October 24th 2024 - A significant milestone for Egypt’s self-sufficiency on polio vaccines was reached on October 21st with the signing of the tech transfer agreement between VACSERA and Bilthoven Biologicals.
Lees verder
Nieuws
SLS Europe and Bilthoven Biologicals receive positive CHMP Opinion for SIILTIBCY® - a novel Tuberculosis Skin Test |
Nieuws
Bilthoven Biologicals and Tonix Pharmaceuticals collaborate on advancing viral vector based Mpox Vaccine |
Binnenkijken bij Nieuws
‘BBio ligt op schema en bereidt zich precies voor zoals de EU het EU Pandemic Preparedness-programma heeft bedacht’. |